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Surgical outcomes of laparoscopic adrenalectomy for 
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single institution
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INTRODUCTION
Our understanding of primary hyperaldosteronism (PHA), 
also known as Conn syndrome, has advanced significantly 
since the first description by Conn approximately 60 years 
ago [1]. The definition of PHA is a group of disorders involving 
excessive production of aldosterone, autonomous from the 
renin-angiotensin system, and nonsuppression by sodium 
loading [2,3]. PHA is considered one of the most common causes 
of secondary hypertension [4]. Several studies have reported 
that PHA accounts for 1% to 10% of cases of hypertension [4-6].
PHA can be detected in either a bilateral or unilateral form. 
If patients are diagnosed with unilateral PHA, the treatment 
of choice is surgery [7,8]. Laparoscopic surgery is preferable to 
open surgery due to better safety, less morbidity, more rapid 
patient recovery, shorter operative times, and greater cosmesis 
[9,10]. The first laparoscopic transperitoneal adrenalectomy 
(LTA) was performed in 1992, and it has since become the 
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Purpose: Recently, posterior retroperitoneoscopic adrenalectomy (PRA) has been reported to have some advantages 
over laparoscopic transperitoneal adrenalectomy (LTA). The objectives of this study were to report our experience over 12 
years with laparoscopic adrenalectomy for primary hyperaldosteronism (PHA) and to examine surgical outcomes of PRA 
compared with LTA in patients with PHA.
Methods: The medical records of 527 patients who underwent minimally invasive adrenalectomy, including LTA or PRA, 
from January 2006 until May 2017 were reviewed at Severance Hospital (Seoul, Korea). Clinicopathologic characteristics 
and surgical outcomes of 146 patients with PHA who underwent LTA (19 patients) or PRA (127 patients) were analyzed 
retrospectively by complete chart review. 
Results: The overall rates of biochemical and clinical cure were 91.1% and 93.1%, respectively. The mean operation time 
of the PRA group was significantly shorter than that of the LTA group (72.3 ± 24.1 minutes vs. 115.7 ± 69.7 minutes, P = 
0.015). The length of hospital stay in the PRA group was significantly shorter than in the LTA group (3.5 ± 1.3 days vs. 4.2 ± 1.6 
days, P = 0.029), and the first meal after surgery came earlier in the PRA group (0.3 ± 0.5 days vs. 0.6 ± 0.5 days, P = 0.049). 
The number of pain-killers used was also significantly smaller in the PRA group (2.3 ± 2.1 vs. 4.3 ± 2.3, P < 0.001). 
Conclusion: PRA offers an alternative or likely superior method for treatment of small adrenal diseases such as PHA, with 
improved surgical outcomes.
[Ann Surg Treat Res 2019;96(5):223-229]
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standard treatment for benign adrenal tumors [11,12]. However, 
the transperitoneal approach has some disadvantages, such 
as risk of visceral damage, ileus after surgery due to bowel 
manipulation, and CO2 retention, among others [13]. Posterior 
retroperitoneoscopic adrenalectomy (PRA) is now regarded as a 
better method for small (less than 7 cm) benign adrenal tumors 
[14]. A variety of studies have demonstrated that, compared 
with LTA, PRA has some advantages, including no manipulation 
of peritoneal organs, direct access to the adrenal gland, shorter 
operation times, less blood loss, less postoperative pain, and 
shorter length of hospital stay [15,16]. In contrast, the possibility 
of kidney injury, a smaller working space, and the difficulty of 
learning the technique are drawbacks to this procedure [17].
In this study, we analyzed cases of laparoscopic adrenalec-
tomy over the last 12 years at our institution. The aims of this 
study were to describe our 12-year experience with laparoscopic 
adrenalectomy for PHA and compare surgical outcomes of PRA 
and LTA in patients with PHA.
METHODS
Patients
We retrospectively reviewed the medical records of 527 
patients who underwent minimally invasive adrenalectomy, 
including LTA or PRA, from January 2006 until May 2017 at 
Severance Hospital (Seoul, Korea). We excluded patients with 
a non-functioning tumor (151 patients), Cushing disease (72 
patients), pheochromocytoma (84 patients), paraganglioma 
(45 patients), or a metastatic adrenal mass (29 patients). 
Clinicopathologic characteristics and surgical outcomes of 146 
patients who underwent LTA or PRA with PHA were analyzed 
by complete retrospective chart review. This study was 
approved by the local Institutional Review Board, which waived 
the requirement for informed consent due to the retrospective 
study design (approval number: 2017-1973-001).
Diagnosis of PHA
The appropriate timing to assess for PHA remains 
controversial. The Endocrine Society recommends tests for 
patients with the following problems [6,18]: (1) stage 2 of Joint 
National Commission, systolic/diastolic >160–179/100–109 
mmHg; (2) stage 3 of Joint National Commission, systolic/
diastolic >180/110 mmHg; (3) spontaneous hypokalemia or 
diuretic-induced hypokalemia in patients with hypertension; 
(4) adrenal incidentaloma in patients with hypertension; 
(5) drug-resistant hypertension; (6) a family history of early 
onset hypertension; (7) cerebrovascular event at less than 40 
years old; and (8) first-degree relatives with PHA. The most 
common screening test for PHA is the serum aldosterone 
and plasma renin activity ratio (ARR), which has higher 
sensitivity and specificity than either aldosterone or plasma 
renin activity alone [6,19]. Following an increased ARR over 
30 in our institution, the second step for diagnosis of PHA is a 
confirmatory test, such as oral salt loading, salt infusion test 
(SIT), fludrocortisone stimulation test, and captopril or losartan 
challenge test [6]. Of these, our hospital mainly uses SIT. All 
patients who were screened and underwent confirmatory tests 
temporarily discontinued their antihypertensive drugs for 
at least 2 weeks, including diuretics, angiotensin-converting 
enzyme inhibitors, angiotensin II receptor blockers, diuretics, 
and β-blockers. Mineralocorticoid receptor antagonists were 
stopped for at least four weeks.
Lateralization with adrenal venous sampling 
CT is significantly useful for identifying adrenal tumors. 
However, even though CT has better sensitivity and specificity 
for finding adrenal tumors than magnetic resonance imaging, 
the detection rate of CT for small tumors (less than 1 cm in 
diameter) is only 50% [6]. Lateralization with adrenal venous 
sampling (AVS) is important for distinguishing unilateral and 
bilateral PHA and for determining the treatment of choice [20]. 
The AVS procedure was described in a previous paper [21]. For 
C-arm CT-assisted AVS, the right femoral vein was accessed 
under ultrasonographic guidance. After catheterization and 
venography of the right adrenal vein, 3-dimensional multiplanar 
reconstruction images by C-arm CT were used to verify proper 
catheter position. Left AVS was performed without a C-arm CT 
scan. Blood samples were drawn in the order of right adrenal 
vein, left adrenal vein, and infrarenal inferior vena cava. The 
success rate of C-arm CT-assisted AVS is approximately 95% in 
our institution [22]. The sensitivity and specificity for detection 
of lateralization are 95% and 100%, respectively [23]. The 
analysis of AVS lateralization was as follows: (1) if lateralization 
index (LI) was more than 4, unilateral PHA, (2) if LI was less 
than 3, bilateral PHA, (3) if LI was over 3 and less than 4, grey 
zone [24].
Surgical procedure
Among patients with PHA, adrenalectomy was performed 
only for unilateral disease identified by diagnostic tests. The 
surgical procedures for PRA and LTA have been previously 
described [14,25,26]. For LTA, patients were placed into the 
lateral decubitus position. Three trocars were usually used 
for left-side adrenalectomy, and 4 trocars were used for right-
side adrenalectomy for liver retraction (Fig. 1) [25,26]. For PRA, 
patients were prepared in the prone position lying on a soft bar 
below both the anterior and superior iliac spine. The surgical 
table was tilted with the head downward about 10°. A 1.5-cm 
skin incision was made just below the lowest tip of the 12th rib. 
A 1.0-cm port site was made about 4 cm medial from the first 
skin incision for the camera, and the third 0.5-cm trocar was 
inserted about 4 cm lateral from the first skin incision along 
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the lowest margin of the 11th rib (Fig. 2). CO2 gas at a pressure 
of 18 to 20 mmHg was injected to maintain the work space. A 
10 mm or 5 mm/30° camera was placed into the medial trocar. 
To expose the adrenal gland, Gerota’s fascia and perinephric fat 
tissue were delicately dissected. The adrenal vein was ligated 
with 5-mm clips, and the specimen was removed from the 
retroperitoneal space using an endoscopic retrieval bag [14,25].
Statistical analysis
All statistical analyses were carried out using IBM SPSS 
Statistics ver. 22.0 (IBM Co., Armonk, NY, USA). We reported 
continuous variables as the mean value with standard deviation 
and categorical variables as numbers with percentages. 
Comparisons between preoperative and postoperative surgical 
outcomes were performed using the paired t-test. Chi-square 
test or Fisher exact test was performed to compare categorical 
variables between LTA and PRA. A statistically significant 
difference was defined as P < 0.05.
RESULTS
Baseline clinicopathologic characteristics
During the study period, a total of 146 patients were 
identified as undergoing LTA or PRA for PHA. Table 1 presents 
baseline clinicopathologic characteristics obtained from the 
complete chart review. The mean age was 48.3 years (range, 
22–81 years). Eighty-five patients (58.2%) were female, and 
the mean body mass index (BMI) was 24.9 kg/m2 (range, 
18.1–41.0 kg/m2). A total of 94 patients (64.4%) underwent AVS 
examination; among them, 71 patients (75.5%) were diagnosed 
with successful lateralization, and the LI of 23 patients (24.4%) 
was less than 4. The mean tumor size was 2.0 cm (range, 
0.5–11.7 cm). The majority of patients (134 [91.8%]) underwent 
laparoscopic surgery, and the rest (12 [8.2%]) were operated on 
using a robotic system. PRA was performed in 127 patients 
(87.0%), and the remaining 19 patients (13.0%) underwent 
LTA. There were 56 patients (38.4%) who underwent right-side 
surgery, while 90 patients (61.6%) received a left-side operation. 
Perioperative outcomes
Surgical and clinical outcomes are summarized in Tables 
2 and 3. The mean operation time was 78.0 minutes (range, 
41–389 minutes), and there were 3 complications, all port-site 
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Fig. 1. Patient and trocar position of laparoscopic transperi-
toneal adrenalectomy.
Fig. 2. Patient and trocar position of posterior retroperitoneo-
scopic adrenalectomy.
Table 1. Baseline clinicopathologic characteristics of the 
study patients (n = 146)
Characteristic Value
Age (yr) 48.3 ± 11.6 (22–81)
Sex, male:female (ratio) 61:85 (1:1.4)
Body mass index (kg/m2) 24.9 ± 4.1 (18.1–41.0)
AVS 
    Yes 94 (64.4)
    No 52 (35.6)
AVS lateralization (ratio)
    ≥4 71/94 (75.5)
    3≤, <4 7/94 (7.4)
    <3 16/94 (17.0)
Tumor size (cm) 2.0 ± 1.4 (0.5–11.7)
Operation method
    Laparoscopic 134 (91.8)
    Robotic 12 (8.2)
Approach
    PRA 127 (87.0)
    LTA 19 (13.0)
Operation side
    Right 56 (38.4)
    Left 90 (61.6)
Values are presented as mean ± standard deviation (range) or 
num ber (%).
AVS, adrenal venous sampling; PRA, posterior retroperitoneo-
scopic adrenalectomy; LTA, lateral transperitoneal adrenalec-
tomy.
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seromas. The mean length of hospital stay was 3.6 days (range, 
2–9 days). The majority of patients (100 [68.5%]) started to eat on 
the day of surgery, and 41 patients (28.1%) started the day after. 
The mean number of pain-killers (tridol 50 mg, keromin 30 mg, 
or pethidine 25 mg) used after surgery was 2.5 injections (range, 
0–10 injections). The mean preoperative and postoperative 
serum ARR were 282.7 (range, 1.12–1,674.4) and 14.2 ng/dL per 
ng/mL/hr (range, 0.02–100.7 ng/dL per ng/mL/hr), respectively. 
The number of biochemically cured (defined as ARR < 30 ng/dL 
per ng/mL/hr and normokalemia without any diuretics in the 6 
months after surgery) patients was 133 (91.1%). The preoperative 
number of antihypertensive drugs used was 2.5 (range, 0–6), 
and the number used after surgery was 0.9 (0–4). The number 
of clinically cured patients after surgery was 136 (93.1%); 63 
(43.1%) were completely cured (defined as blood pressure less 
than 140/90 mmHg without the aid of antihypertensive drugs 
in the 6 months after surgery) and 73 (50.0%) were improved 
(defined as a reduction of at least one antihypertensive drug in 
the 6 months after surgery). Ten patients (6.9%) were unable to 
reduce the number of anti-hypertensive drugs after surgery. 
As shown in Table 4, ARR and the number of antihy-
pertensive drugs used were compared between preoperative 
and postoperative periods. The ARR was significantly lower 
after surgery (282.7 ± 344.4 ng/dL per ng/mL/hr vs. 14.2 
± 18.1 ng/dL per ng/mL/hr, P < 0.001), and the number of 
antihypertensive drugs used improved significantly after 
surgery (2.5 ± 1.2 vs. 0.9 ± 0.9, P < 0.001).
Comparison of surgical outcomes between PRA 
and LTA groups
Table 5 compares baseline clinicopathologic characteristics 
and perioperative outcomes between the PRA and LTA groups. 
There was no statistically significant difference in age, sex, 
BMI, tumor size, preoperative ARR, postoperative ARR, or pre-
operative number of antihypertensive drugs used between the 
2 groups. 
Left-side surgery was predominant in the LTA group (P = 0.001). 
The mean operation time for the PRA group was significantly 
shorter than that of the LTA group (72.3 ± 24.1 minutes vs. 
115.7 ± 69.7 minutes, P = 0.015). The length of hospital stay in 
the PRA group was significantly shorter than in the LTA group 
(3.5 ± 1.3 days vs. 4.2 ± 1.6 days, P =0.029), and the time to 
first meal after surgery was also shorter in the PRA group 
(0.3 ± 0.5 days vs. 0.6 ± 0.5 days, P = 0.049). The number 
of pain-killers used was significantly fewer in the PRA group 
(2.3 ± 2.1 vs. 4.3 ± 2.3, P < 0.001). However, the postoperative 
number of antihypertensive drugs used in the LTA group was 
significantly fewer than in the PRA group (0.3 ± 0.5 vs. 0.9 ± 0.9, 
P = 0.011).
DISCUSSION
PHA has likely been underestimated because of the diffi-
culty of diagnosis without suspicion. ARR is widely used 
as a screening test for PHA in hypertensive patients. AVS is 
the gold standard for differentiating between unilateral and 
Table 2. Surgical outcomes of study patients who underwent 
adrenalectomy (n = 146)
Variable Value
Operation time (min) 78.0 ± 36.4 (41–389)
Complication 3 (2.1)
Length of hospital stay (day) 3.6 ± 1.4 (2–9)
First diet after operation
    POD #0 100 (68.5)
    POD #1 41 (28.1)
    POD #2 5 (3.4)
No. of pain-killer used 2.5 ± 2.3 (0–10) 
Values are presented as mean ± standard deviation (range) or 
number (%).
POD, postoperative day.
Table 3. Clinical outcomes for primary hyperaldosteronism 
after operation
Variable Value
Preoperative ARR (ng/dL per 
ng/mL/hr)
282.7 ± 344.4 (1.12–1,674.4)
Postoperative ARR (ng/dL per 
ng/mL/hr)
14.2 ± 18.1 (0.02–100.7)
No. of biochemically cured 133 (91.1)
Preoperative No. of 
antihypertensive drugs used
2.5 ± 1.2 (0–6)
Postoperative No. of 
antihypertensive drugs used
0.9 ± 0.9 (0–4)
No. of clinically cured 136 (93.1)
    Completely cured 63 (43.1)
    Improved 73 (50.0)
    Sustained 10 (6.9)
Values are presented as mean ± standard deviation (range) or 
number (%).
ARR, serum aldosterone and plasma renin activity ratio.
Table 4. Comparison of perioperative ARR and number of 
antihypertensive drugs used
Variable Preoperative Postoperative P-value
ARR (ng/dL per ng/
mL/hr)
282.7 ± 344.4 
(1.1–1,674.4)
14.2 ± 18.1 
(0.02–100.7)
<0.001
No. of 
antihypertensives 
used
2.5 ± 1.2 
(0–6)
0.9 ± 0.9 
(0–4)
<0.001
Values are presented as mean ± standard deviation (range) or 
number (%).
ARR, serum aldosterone and plasma renin activity ratio.
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bilateral disease. In our institution, C-arm CT-assisted AVS 
has been performed for lateralization since 2011 [22]. In this 
study, 92 patients (73.6%) who underwent adrenalectomy 
after 2011 had an AVS examination. In contrast, only 2 of 21 
patients (9.5%) who underwent adrenalectomy before 2011 had 
an AVS examination. Even though 23 of 94 patients (24.4%) 
were diagnosed with an LI less than 4, they still underwent 
adrenalectomy. PHA was suspected because the suppression 
index (defined as the measure of inhibition of aldosterone 
secretion in the adrenal gland contralateral to an ipsilateral 
lesion [24]), which was calculated as the ratio of the cortisol-
corrected aldosterone ratio (AC) of the nondominant adrenal 
gland to the peripheral AC, was less than 1 or clinically uni-
lateral [27]. 
Cure rate in patients with PHA after adrenalectomy has been 
reported in the range from 35% to 60% in previous studies 
[2,28]. Our cure rate was 43.1% and improved rate was 50%. 
However, the remaining 10 patients (6.9%) maintained their 
anti-hypertensive drug use even after surgery, possibly due to a 
longer hypertension morbidity period or bilateral PHA.
The treatment of choice for unilateral PHA is surgery, 
minimally invasive adrenalectomy in particular, which is 
identified as safe; surprisingly, there were only 3 complications 
of port-site seromas in this study. There are 2 minimally 
invasive approach methods: LTA and PRA. LTA is the most 
widely performed method and has some advantages in terms 
of large working space and a familiar anatomical view. On the 
other hand, even though PRA is only recommended for small 
adrenal tumors less than 7 cm, it has many advantages, such 
as direct exposure of the adrenal gland, no manipulation of 
adjacent organs, and a relatively shorter operation time. 
To compare surgical outcomes between LTA and PRA, we 
used several perioperative parameters, including operation 
time, the number of pain-killers used after surgery, length of 
hospital stay, and time to first meal after surgery. Previous 
studies report that the mean operation time is shorter for PRA 
than for LTA [29], and our findings agreed. The requirement 
for pain-killers was also significantly lower in the PRA group, 
possibly because of the shorter operation time, small surgical 
dissection, and need for only three trocars regardless of the side 
of the operation. The same reasons may have also influenced 
the length of hospital stay and time to first meal after surgery. 
However, the only three minor complications occurred in the 
PRA group; all were port-site seromas that were taken care of by 
a simple dressing in outpatient care.
We note that there are some limitations to the present study 
such as its retrospective case-control design and restriction to a 
single tertiary institution. The LTA group had relatively fewer 
patients than the PRA group because PRA was predominantly 
performed for adrenal diseases after 2009 in our institution. 
In accordance with the patients’ hypertension morbidity 
period, the degree of reduction in postoperative number of 
antihypertensive drugs used also varied considerably and 
was not described in a majority of patients’ medical records. 
Furthermore, we excluded perioperative blood pressure 
and potassium levels, because most patients (85.6%) had 
Kwangsoon Kim, et al: Surgical outcomes after laparoscopic adrenalectomy
Table 5. Comparison of baseline characteristics and perioperative outcomes between PRA and LTA groups
Variable PRA (n = 127) LTA (n = 19) P-value
Age (yr) 48.7 ± 11.8 45.8 ± 10.4 0.307
Sex, male:female (ratio) 53:74 (1:1.4) 8:11 (1:1.4) 0.975
Body mass index (kg/m2) 25.1 ± 4.1 23.9 ± 4.5 0.252
Operation side 0.001
    Right 55 (43.3) 1 (5.2)
    Left 72 (56.7) 18 (94.7)
Operation time (min) 72.3 ± 24.1 115.7 ± 69.7 0.015
Tumor size (cm) 1.9 ± 1.1 2.5 ± 2.6 0.310
Length of hospital stay (day) 3.5 ± 1.3 4.2 ± 1.6 0.029
First diet after operation 0.3 ± 0.5 0.6 ± 0.5 0.049
    POD #0 92 (72.4) 8 (42.1)
    POD #1 30 (23.6) 11 (57.9)
    POD #2 5 (3.9) 0 (0)
No. of pain-killer used 2.3 ± 2.1 4.3 ± 2.4 <0.001
Preoperative ARR (ng/dL per ng/mL/hr) 284.3 ± 336.6 296.2 ± 410.8 0.895
Postoperative ARR (ng/dL per ng/mL/hr) 14.7 ± 18.5 11.3 ± 15.0 0.475
Preoperative No. of antihypertensive drugs used 2.4 ± 1.1 2.5 ± 1.2 0.699
Postoperative No. of antihypertensive drugs used 0.9 ± 0.9 0.3 ± 0.5 0.011
Values are presented as mean ± standard deviation or number (%).
PRA, posterior retroperitoneoscopic adrenalectomy; LTA, lateral transperitoneal adrenalectomy; POD, postoperative day; ARR, serum 
aldosterone and plasma renin.
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taken spironolactone and potassium chloride medication 
since diagnosis of PHA and underwent adrenalectomy in a 
normalizing condition of blood pressure and potassium status. 
Finally, we simply compared the number of pain-killers used 
between the 2 groups without consideration of dose or type of 
pain-killer, and pain scores such as visual analog scale were not 
evaluated after surgery.
In conclusion, PHA is a complex disease from diagnosis to 
treatment. LTA is still the most widely used surgical approach 
for unilateral adrenal diseases. In our study, we described the 
range of disease cure rate through laparoscopic adrenalectomy, 
with excellent surgical outcomes for the management of PHA 
using PRA. PRA offers an alternative or likely superior method 
for treating small adrenal diseases such as PHA, with improved 
surgical outcomes. 
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